메뉴 건너뛰기
Journal of the American Academy of Dermatology
Volumn 59, Issue 5 SUPPL., 2008, Pages
Efalizumab treatment associated with Candida colitis
Author keywords

[No Author keywords available]
Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; CALCIUM; CARVEDILOL; CASPOFUNGIN; CEFTRIAXONE; CLOPIDOGREL; DEXTROPROPOXYPHENE; DIGOXIN; EFALIZUMAB; EZETIMIBE PLUS SIMVASTATIN; IRBESARTAN; METRONIDAZOLE; SPIRONOLACTONE; UBIDECARENONE; VANCOMYCIN;
EID: 53349122009     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.06.035     Document Type: Article
Times cited : (5)
References (5)
  • 1
    • 27744466915 scopus 로고    scopus 로고
    • Incidence of infection during efalizumab therapy for psoriasis: analysis of the clinical trial experience
    • Langley R.G.B., Carey W.P., Rafal E.S., Tyring S.K., Caro I., Wang X., et al. Incidence of infection during efalizumab therapy for psoriasis: analysis of the clinical trial experience. Clin Ther 27 (2005) 1317-1328
    • (2005) Clin Ther , vol.27 , pp. 1317-1328
    • Langley, R.G.B.1    Carey, W.P.2    Rafal, E.S.3    Tyring, S.K.4    Caro, I.5    Wang, X.6
  • 2
    • 53349130828 scopus 로고    scopus 로고
    • Carey W, Toth DP, Bissonnette R, Langley R. No evidence for increased risk of infection during efalizumab treatment: a review of the clinical data. Presented at the 13th Annual Meeting of the European Academy of Dermatology and Venereology, Florence, Italy, November 18-21, 2004. Poster #79.
    • Carey W, Toth DP, Bissonnette R, Langley R. No evidence for increased risk of infection during efalizumab treatment: a review of the clinical data. Presented at the 13th Annual Meeting of the European Academy of Dermatology and Venereology, Florence, Italy, November 18-21, 2004. Poster #79.
  • 3
    • 33749330192 scopus 로고    scopus 로고
    • Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis: review of clinical data
    • Papp K.A., Camisa C., Stone S.P., Caro I., Wang X., Compton P., et al. Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis: review of clinical data. Part II. J Cutan Med Surg 9 (2005) 313-323
    • (2005) Part II. J Cutan Med Surg , vol.9 , pp. 313-323
    • Papp, K.A.1    Camisa, C.2    Stone, S.P.3    Caro, I.4    Wang, X.5    Compton, P.6
  • 4
    • 35348918394 scopus 로고    scopus 로고
    • Disseminated cryptococcal infection in a patient with severe psoriasis treated with efalizumab, methotrexate and ciclosporin
    • Tuxen A.J., Yong M.K., Street A.C., and Dolianitis C. Disseminated cryptococcal infection in a patient with severe psoriasis treated with efalizumab, methotrexate and ciclosporin. Br J Dermatol 157 (2007) 1067-1068
    • (2007) Br J Dermatol , vol.157 , pp. 1067-1068
    • Tuxen, A.J.1    Yong, M.K.2    Street, A.C.3    Dolianitis, C.4
  • 5
    • 1842487380 scopus 로고    scopus 로고
    • Generalized pustular psoriasis following withdrawal of efalizumab
    • Gaylor M.N., and Duvic M. Generalized pustular psoriasis following withdrawal of efalizumab. J Drugs Dermatol 3 (2004) 77-79
    • (2004) J Drugs Dermatol , vol.3 , pp. 77-79
    • Gaylor, M.N.1    Duvic, M.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.